IDX Stock Overview
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 1/6 |
Integral Diagnostics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$2.46 |
| 52 Week High | AU$3.55 |
| 52 Week Low | AU$1.63 |
| Beta | 0.76 |
| 1 Month Change | 9.09% |
| 3 Month Change | 24.87% |
| 1 Year Change | -26.79% |
| 3 Year Change | -45.82% |
| 5 Year Change | -20.13% |
| Change since IPO | 29.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| IDX | AU Healthcare | AU Market | |
|---|---|---|---|
| 7D | -2.0% | -2.1% | -1.5% |
| 1Y | -26.8% | -21.0% | 5.7% |
Return vs Industry: IDX underperformed the Australian Healthcare industry which returned -21% over the past year.
Return vs Market: IDX underperformed the Australian Market which returned 5.7% over the past year.
Price Volatility
| IDX volatility | |
|---|---|
| IDX Average Weekly Movement | 4.5% |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.6% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: IDX has not had significant price volatility in the past 3 months.
Volatility Over Time: IDX's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 2,010 | Ian Kadish | www.integraldiagnostics.com.au |
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.
Integral Diagnostics Limited Fundamentals Summary
| IDX fundamental statistics | |
|---|---|
| Market cap | AU$575.43m |
| Earnings (TTM) | -AU$57.85m |
| Revenue (TTM) | AU$456.31m |
1.2x
P/S Ratio-9.8x
P/E RatioIs IDX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IDX income statement (TTM) | |
|---|---|
| Revenue | AU$456.31m |
| Cost of Revenue | AU$307.71m |
| Gross Profit | AU$148.60m |
| Other Expenses | AU$206.46m |
| Earnings | -AU$57.85m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 27, 2024
| Earnings per share (EPS) | -0.25 |
| Gross Margin | 32.57% |
| Net Profit Margin | -12.68% |
| Debt/Equity Ratio | 73.3% |
How did IDX perform over the long term?
See historical performance and comparison